tiprankstipranks

Justin Chakma Insider Profile

4 Followers
Justin Chakma, CBO at ARS Pharmaceuticals, holds 136.38K shares in ARS Pharmaceuticals (Ticker: SPRY).
tipranks
Justin Chakma

Justin Chakma
ARS Pharmaceuticals (SPRY)
CBO

Ranked #45,113 out of 99,797 Corporate Insiders

Profitable Transactions

67%
2 out of 3 Profitable Transactions

Average Return

+2.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Justin Chakma's holdings

Insider Roles

ARS Pharmaceuticals
(SPRY)
CBO
Roles that Justin Chakma holds in companies

Most Profitable Insider Trade

Stock:
ARS Pharmaceuticals
(SPRY)
Rating:Informative Sell
Date:Nov 27, 2024 - Today
Return:+3.50%
The most profitable trade made by Justin Chakma

Justin Chakma's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARS Pharmaceuticals
Dec 13, 2024
CBO
Uninformative Buy
137.83K
$1.52M
Success Rate for
SPRY
2 out of 3 profitable transactions on
SPRY
67%
Average Return for
SPRY
Average return per transaction on
SPRY
+2.07%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 10, 2022
Uninformative Buy
$0.00
-
$0.00
Dec 04, 2024
Uninformative Buy
$75.60K
-
$0.84
Dec 06, 2024
Uninformative Buy
$121.50K
-
$0.84
Dec 12, 2024
Uninformative Buy
$42.00K
-
$0.84
Dec 13, 2024
Uninformative Buy
$137.83K
-
$0.95
List of latest transactions for each holding click on a transaction to see Justin Chakma's performance on stock

Justin Chakma insider profile FAQ

What is the percentage of profitable transactions made by Justin Chakma?
The percentage of profitable transactions made by Justin Chakma is 67%.
    What is the average return per transaction made by Justin Chakma?
    The average return per transaction made by Justin Chakma is 2.00%.
      What stocks does Justin Chakma hold?
      Justin Chakma holds: SPRY stocks.
        What was Justin Chakma’s latest transaction?
        Justin Chakma latest transaction was an Uninformative Buy of $137.83K.
          What was Justin Chakma's most profitable transaction?
          Justin Chakma’s most profitable transaction was an Informative Sell of SPRY stock on November 27, 2024. The return on the trade was 3.50%.
            What is Justin Chakma's role in ARS Pharmaceuticals?
            Justin Chakma's role in ARS Pharmaceuticals is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.